These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35268533)

  • 1. How Is Spinal Cord Function Measured in Degenerative Cervical Myelopathy? A Systematic Review.
    Soufi KH; Perez TM; Umoye AO; Yang J; Burgos M; Martin AR
    J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive effect of cervical spinal cord compression and corresponding segmental paravertebral muscle degeneration on the severity of symptoms in patients with cervical spondylotic myelopathy.
    Lin T; Wang Z; Chen G; Liu W
    Spine J; 2021 Jul; 21(7):1099-1109. PubMed ID: 33785472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ancillary outcome measures for assessment of individuals with cervical spondylotic myelopathy.
    Kalsi-Ryan S; Singh A; Massicotte EM; Arnold PM; Brodke DS; Norvell DC; Hermsmeyer JT; Fehlings MG
    Spine (Phila Pa 1976); 2013 Oct; 38(22 Suppl 1):S111-22. PubMed ID: 23963009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Upper Limb Impairment Related to Degenerative Cervical Myelopathy: Development of a Sensitive Hand Assessment (Graded Redefined Assessment of Strength, Sensibility, and Prehension Version Myelopathy).
    Kalsi-Ryan S; Riehm LE; Tetreault L; Martin AR; Teoderascu F; Massicotte E; Curt A; Verrier MC; Velstra IM; Fehlings MG
    Neurosurgery; 2020 Mar; 86(3):E292-E299. PubMed ID: 31792501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early neurological changes in aging cervical spine: insights from PROMIS mobility assessment.
    Hameed S; Muhammad F; Haynes G; Smith L; Khan AF; Smith ZA
    Geroscience; 2024 Jun; 46(3):3123-3134. PubMed ID: 38198027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Outcomes of Surgical Treatment for Ossification of the Posterior Longitudinal Ligament Versus Other Forms of Degenerative Cervical Myelopathy: Results from the Prospective, Multicenter AOSpine CSM-International Study of 479 Patients.
    Nakashima H; Tetreault L; Nagoshi N; Nouri A; Arnold P; Yukawa Y; Toyone T; Tanaka M; Zhou Q; Fehlings MG
    J Bone Joint Surg Am; 2016 Mar; 98(5):370-8. PubMed ID: 26935459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of quality of life and functional outcome measures for cervical spondylotic myelopathy.
    Lubelski D; Alvin MD; Nesterenko S; Sundar SJ; Thompson NR; Benzel EC; Mroz TE
    J Neurosurg Spine; 2016 Mar; 24(3):483-9. PubMed ID: 26613280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM).
    Yanez Touzet A; Bhatti A; Dohle E; Bhatti F; Lee KS; Furlan JC; Fehlings MG; Harrop JS; Zipser CM; Rodrigues-Pinto R; Milligan J; Sarewitz E; Curt A; Rahimi-Movaghar V; Aarabi B; Boerger TF; Tetreault L; Chen R; Guest JD; Kalsi-Ryan S; McNair AG; Kotter M; Davies B;
    BMJ Open; 2022 Jan; 12(1):e057650. PubMed ID: 35046007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degenerative cervical myelopathy: establishing severity thresholds for neuromotor dysfunction in the aging spine using the NIH Toolbox Assessment Scale.
    Muhammad F; Hameed S; Haynes G; Mohammadi E; Khan AF; Shakir H; Smith ZA
    Geroscience; 2024 Apr; 46(2):2197-2206. PubMed ID: 37880488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional outcome instruments used for cervical spondylotic myelopathy: interscale correlation and prediction of preference-based quality of life.
    Whitmore RG; Ghogawala Z; Petrov D; Schwartz JS; Stein SC
    Spine J; 2013 Aug; 13(8):902-7. PubMed ID: 23523443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the Neurological Examination Correlate with Patient-Perceived Outcomes in Degenerative Cervical Myelopathy?
    McGregor SMK; Detombe SA; Goncalves S; Doyle-Pettypiece P; Bartha R; Duggal N
    World Neurosurg; 2019 Dec; 132():e885-e890. PubMed ID: 31382071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical spinal cord morphometrics in degenerative cervical myelopathy: quantification using semi-automated normalized technique and correlation with neurological dysfunctions.
    Muhammad F; Weber KA; Bédard S; Haynes G; Smith L; Khan AF; Hameed S; Gray K; McGovern K; Rohan M; Ding L; Van Hal M; Dickson D; Tamimi MA; Parrish T; Dhaher Y; Smith ZA
    Spine J; 2024 Nov; 24(11):2045-2057. PubMed ID: 39038658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Spondylolisthesis Affect Severity and Outcome of Degenerative Cervical Myelopathy? A Systematic Review and Meta-analysis.
    Gondar R; Nouri A; Jannelli G; Schaller K; Tessitore E
    Global Spine J; 2021 Sep; 11(7):1134-1141. PubMed ID: 33063537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Surgery for Mild Degenerative Cervical Myelopathy: Results of the AOSpine North America and International Prospective Multicenter Studies.
    Badhiwala JH; Witiw CD; Nassiri F; Akbar MA; Mansouri A; Wilson JR; Fehlings MG
    Neurosurgery; 2019 Apr; 84(4):890-897. PubMed ID: 29684181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Study of Degenerative Cervical Myelopathy and the Surgical Management Within Northern Ireland.
    Saunders LM; Sandhu HS; McBride L; Maniarasu VS; Taylor S; Dhokia R
    Cureus; 2023 Nov; 15(11):e49513. PubMed ID: 38024056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging assessment of degenerative cervical myelopathy: a review of structural changes and measurement techniques.
    Nouri A; Martin AR; Mikulis D; Fehlings MG
    Neurosurg Focus; 2016 Jun; 40(6):E5. PubMed ID: 27246488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of nonoperatively managed degenerative cervical myelopathy: an ambispective longitudinal cohort study in 117 patients.
    Martin AR; Kalsi-Ryan S; Akbar MA; Rienmueller AC; Badhiwala JH; Wilson JR; Tetreault LA; Nouri A; Massicotte EM; Fehlings MG
    J Neurosurg Spine; 2021 Jun; 34(6):821-829. PubMed ID: 33836502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient phenotypes associated with outcome following surgery for mild degenerative cervical myelopathy: a principal component regression analysis.
    Badhiwala JH; Witiw CD; Nassiri F; Jaja BNR; Akbar MA; Mansouri A; Merali Z; Ibrahim GM; Wilson JR; Fehlings MG
    Spine J; 2018 Dec; 18(12):2220-2231. PubMed ID: 29746963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of the 30-m walking test in patients with degenerative cervical myelopathy: results from two prospective multicenter cohort studies.
    Bohm PE; Fehlings MG; Kopjar B; Tetreault LA; Vaccaro AR; Anderson KK; Arnold PM
    Spine J; 2017 Feb; 17(2):211-217. PubMed ID: 27592193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced MRI metrics improve the prediction of baseline disease severity for individuals with degenerative cervical myelopathy.
    Al-Shawwa A; Ost K; Anderson D; Cho N; Evaniew N; Jacobs WB; Martin AR; Gaekwad R; Tripathy S; Bouchard J; Casha S; Cho R; duPlessis S; Lewkonia P; Nicholls F; Salo PT; Soroceanu A; Swamy G; Thomas KC; Yang MMH; Cohen-Adad J; Cadotte DW
    Spine J; 2024 Sep; 24(9):1605-1614. PubMed ID: 38679077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.